Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

CONCLUSION: Our findings support the use of PD-1 blockade in HIV-cHL for the same indications as the general population with cHL.PMID:38714474 | DOI:10.1016/j.clml.2024.03.011
Source: The Medical Clinics of North America - Category: General Medicine Authors: Source Type: research